Computer-designed repurposing of chemical wastes into drugs

As the chemical industry continues to produce considerable quantities of waste chemicals, it is essential to devise ‘circular chemistry’ schemes to productively back-convert at least a portion of these unwanted materials into useful products. Despite substantial progress in the degradation of some classes of harmful chemicals, work on ‘closing the circle’—transforming waste substrates into valuable products—remains fragmented and focused on well known areas.(1)

Comprehensive analyses of which valuable products are synthesizable from diverse chemical wastes are difficult because even small sets of waste substrates can, within few steps, generate millions of putative products, each synthesizable by multiple routes forming densely connected networks. Tracing all such syntheses and selecting those that also meet criteria of process and ‘green’ chemistries is, arguably, beyond the cognition of human chemists. Here we show how computers equipped with broad synthetic knowledge can help address this challenge.(1)

Using the forward-synthesis Allchemy platform, researchers generated a giant synthetic networks emanating from approximately 200 waste chemicals recycled on commercial scales. What they retrieve from these networks is tens of thousands of routes leading to approximately 300 important drugs and agrochemicals; the algorithm also ranks these syntheses according to the accepted metrics of sustainable chemistry. Several of these routes were validated by experiment, including an industrially realistic demonstration on a ‘pharmacy on demand’ flow-chemistry platform. Wide adoption of computerized waste-to-valuable algorithms can accelerate productive reuse of chemicals that would otherwise incur storage or disposal costs, or even pose environmental hazards. (1)

• The interactive Allchemy web application is freely available for academic users

Co-Authors: Agnieszka Wołos, Dominik Koszelewski2, Rafał Roszak, Sara Szymkuć, Martyna Moskal, Ryszard Ostaszewski, Brenden T. Herrera, Josef M. Maier, Gordon Brezicki, Jonathon Samuel, Justin A. M. Lummiss, D. Tyler McQuade, Luke Rogers & Bartosz A. Grzybowski

• Acknowledgements: Development of the medicinal chemistry modules within the Allchemy platform (by A.W., R.R., S.S., M.M. and B.A.G.) has been supported by internal funds of Allchemy, Inc. D.K. and R.O. gratefully acknowledge funding from the National Science Centre, Poland which supported the laboratory-scale syntheses described in this paper. Analysis of pathways and writing of the paper by B.A.G. was supported by the Institute for Basic Science, Korea. Development of the manufacturing processes for COVID-19 medications was supported by DARPA & CARES Act grant  

Research Article posted in Nature on April 27th, 2022

• Wołos, A., Koszelewski, D., Roszak, R. et al. Computer-designed repurposing of chemical wastes into drugs. Nature604, 668–676 (2022). https://doi.org/10.1038/s41586-022-04503-9